Sector: Pharmaceuticals & Biotechnology

Small Cap

Hester Biosciences Share Price

HESTERBIO

₹2,545

424.10(20.00%)

13th Jul 2026 | 3:26 PM

NSE : HESTERBIO

Open Free Demat Account

Hester Biosciences Performance

Price Movement

₹2545.00

₹2110.00

₹2545.00

↘ Today's Low↗ Today's High

1 Year Performance

₹2545.00

₹1239.30

₹2350.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,545.00

Low₹2,110.00

Open at₹2,110.00

Prev Close₹2,120.90

Volumes4.82 L

Avg Price₹2,492.98

Lower Circuit₹1,696.80

Upper Circuit₹2,545.00

Historical Performance

3M High₹2,315.00

3M Low₹1,421.00

1 Yr High₹2,350.00

1 Yr Low₹1,239.30

3 Yr High₹3,379.00

3 Yr Low₹1,239.30

5 Yr High₹3,379.00

5 Yr Low₹1,239.30

Summary

As of 13-07-2026 18:25, Hester Biosciences Ltd. share price today is ₹0, with a change of ₹-2120.90 (-100.00%) from the previous close of ₹2120.9. The stock opened at ₹2110 and traded between ₹2110 and ₹2545, with a total traded volume of 482367 shares. The company has a market capitalization of ₹1804.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2350 and ₹1239.3, respectively.

Hester Biosciences Ltd. valuation metrics include a P/E ratio of 32.4, EPS of ₹67.57, and book value of ₹5.00. Profitability indicators show ROE of 15.44% along with a dividend yield of 0.3%. Hester Biosciences Ltd. has reported revenue of ₹332.6 Cr and net profit of ₹55.64 Cr.

Hester Biosciences Ltd. technical indicators include Day RSI at 54.16, Day MFI at 77.93, Day ADX at 53.18. Additional indicators include Commodity Channel Index (CCI) at -7.6 and Williams %R at -78.33. Momentum indicators show Day MACD at 54.78, Day MACD Signal Line at 74.56, DayATR at 93.46. Rate of Change indicators for Hester Biosciences Ltd. include ROC125 at 33.17 and ROC21 at 9.37.

Exponential moving averages include EMA5 at ₹2131.8, EMA10 at ₹2140.9, EMA12 at ₹2138.4, EMA20 at ₹2111.7, EMA26 at ₹2083.6, EMA50 at ₹1968.4, EMA100 at ₹1829.6, EMA200 at ₹1768.9. Simple moving averages include SMA5 at ₹2137, SMA10 at ₹2161.4, SMA20 at ₹2130.6, SMA30 at ₹2076.6, SMA50 at ₹1954.9, SMA100 at ₹1717.1, SMA150 at ₹1661.4, SMA200 at ₹1681.9.

Support levels for Hester Biosciences are placed at First Support ₹2101.73, Second Support ₹2082.57, Third Support ₹2055.93. Resistance levels are seen at First Resistance ₹2147.53, Second Resistance ₹2174.17, Third Resistance ₹2193.33. Hester Biosciences Ltd. shareholding pattern shows promoter holding at 53.73%, FII holding at 0.38%, DII holding at 0%, public holding at 45.88%.

Hester Biosciences Fundamentals

Market Cap

Above industry Median

1,804.20 Cr.

PE Ratio (TTM)

Above industry Median

32.40

Dividend Yield

Below industry Median

0.30

Net Profit TTM

102.4% incr over last year

55.64

Net Profit Growth

102.4% incr over last year

55.64

PEG Ratio

Above industry Median

0.30

ROE

76.7% incr over last year

15.44

Operating Revenue TTM

332.60

Operating Revenue Growth

6.9% incr over last year

Book Value

Above industry Median

MFI

MFI Overbought

77.93

RSI

RSI is mid-range

54.16

EPS (TTM)

67.57

Debt to Equity

0.52

Face Value

Operating Profit Margin Qtr.

25.32

Operating Profit Qtr.

34.33

Net Profit Qtr.

15.98

Operating Revenue Qtr.

100.11

PB Ratio

Hester Biosciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	93.71	70.35	64.58	63.49	76.67
Operating Expense	62.25	53.64	52.70	51.08	62.97
Operating Profit	31.46	16.72	11.88	12.41	13.70
Depreciation	3.68	2.21	2.20	2.16	2.03
Interest	4.09	0.90	1.27	0.90	1.25
Tax	8.49	3.97	2.67	2.45	1.85
Net Profit	26.38	10.67	7.21	7.84	9.64

Hester Biosciences Technicals

Hester Biosciences Ltd. EMA & SMA

₹2545.00

442.80 (21.06%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2131.8

Day EMA10 ₹2140.9

Day EMA12 ₹2138.4

Day EMA20 ₹2111.7

Day EMA26 ₹2083.6

Day EMA50 ₹1968.4

Day EMA100 ₹1829.6

Day EMA200 ₹1768.9

Hester Biosciences Support and Resistance

Resistance

First Resistance₹2147.53

Second Resistance₹2174.17

Third Resistance₹2193.33

Support

First Support₹2101.73

Second Support₹2082.57

Third Support₹2055.93

Technical Indicators

Day RSI54.16

Day MFI77.93

Day ADX53.18

Day Commodity Channel Index-7.60

William-78.33

Day MACD54.78

Day MACD Signal Line74.56

Day ATR93.46

Day ROC12533.17

Day ROC219.37

Hester Biosciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	53.7	53.7	53.7	53.7	53.7	53.7
FII	0.6	0.9	0.5	0.5	0.5	0.4
DII	0	0	0	0	0	0
Public	45.6	45.4	45.7	45.7	45.8	45.9

Hester Biosciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.28 K	3.61 K	63.26%
Week	3.13 K	5.01 K	62.39%
1 Month	4.68 K	10.43 K	44.84%
6 Month	4.46 K	10.2 K	43.74%

Hester Biosciences SWOT Analysis

Strengths25

Weakness0

Opportunity0

Threats0

High DVM Mid and Small Caps (subscription)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Companies with 10% increase in share price over three months, with rising net profit growth

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Hester Biosciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
14 Jul, 2026	11	FINAL	14 Jul, 2026	Equity Share
06 Aug, 2025	7	FINAL	06 Aug, 2025	Equity Share
22 Aug, 2024	6	FINAL		Equity Share
13 Sep, 2023	8	FINAL		Equity Share
11 Aug, 2022	10	FINAL		Equity Share
05 Aug, 2021	10	FINAL		Equity Share
27 Aug, 2020	6.6	FINAL		Equity Share
18 Jul, 2019	7	FINAL		Equity Share
09 Nov, 2018	2	INTERIM	12 Nov, 2018	Equity Share
30 Aug, 2018	2	INTERIM	31 Aug, 2018	Equity Share

Hester Biosciences Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹587	₹5.38	₹175.59	₹15.41	₹541.20	₹63.75
% Change	-0.19%	-0.55%	-2.00%	-1.15%	0.56%	2.69%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	₹176.50	₹502.55	₹237.47
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	₹27.81	₹57.92	₹-3.28
PE TTM	-	-1.30	46.80	29.80	26.90	-102.90
1 Year Return	50.03	441	42.2	71.32	-25.91	-40.37
ROCE	3.56	-5.63	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 23.12

+1.99%

WINDLAS

Windlas Biotech Ltd.

₹ 853.45

+2.83%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.82

+5.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 586.50

+3.09%

ZIMLAB

Zim Laboratories Ltd.

₹ 115.89

+2.00%

MEDICO

Medico Remedies Ltd.

₹ 39.28

-1.08%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 196.87

+0.52%

LASA

Lasa Supergenerics Ltd.

₹ 7.28

-3.32%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 331.00

+0.35%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 344.20

-1.29%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.00

-2.97%

BROOKS

Brooks Laboratories Ltd.

₹ 69.80

-0.91%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2807.00

-1.75%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 208.70

+2.00%

ALPA

Alpa Laboratories Ltd.

₹ 68.93

+1.00%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 398.10

-1.14%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.18

-0.09%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.90

+0.54%

INDOCO

Indoco Remedies Ltd.

₹ 258.00

-0.86%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 235.65

-4.38%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 607.00

-1.38%

PANACEABIO

Panacea Biotec Ltd.

₹ 542.75

-0.70%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 237.00

-3.40%

THEMISMED

Themis Medicare Ltd.

₹ 116.33

-0.54%

FAQ's on HESTERBIO

What is the current share price of Hester Biosciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Hester Biosciences Ltd. is ₹ 2545 on the NSE and ₹ 2531.25 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Hester Biosciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Hester Biosciences Ltd. is approximately ₹ 1804.2 Cr.

What are the PE and PB ratios for Hester Biosciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Hester Biosciences Ltd. is 32.4, and the Price-to-Book (PB) ratio is 5.

What is the 52-Week High and Low for Hester Biosciences Ltd.?

Over the past 52 weeks, the highest price reached by Hester Biosciences Ltd. shares was ₹ 2350, and the lowest price was ₹ 1239.3.

What is the current dividend yield for Hester Biosciences Ltd.?

As of 6 June 2025, the dividend yield for Hester Biosciences Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Hester Biosciences Ltd.?

Significant shareholdings in Hester Biosciences Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Hester Biosciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Hester Biosciences Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Hester Biosciences Ltd.?

Hester Biosciences Ltd. last declared a FINAL dividend of ₹ 11 per share for the financial period ending 2026. The record date was set as 2026-07-14, and the payment was/is scheduled around 2026-07-14. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy